Commences distribution of Imdur® in Europe
Oslo, 22 September 16 2016 – Navamedic ASA (Navamedic), the Norwegian medtech and pharmaceutical products company, today announced it has commenced distribution of angina prevention medicine, Imdur® (isosorbide mononitrate), in the Nordic markets. The initiation of the distribution is the first step in the long-term strategic partnership with TopRidge Pharma Limited (TopRidge Pharma).
Quarterly Report Q2 2016
Navamedic ASA Quarterly report for Q2 2016